Biotech Fluidics launches DEGASi NG inline degasser platform
Biotech Fluidics has streamlined and upgraded its DEGASi® inline degasser range with the launch of the new DEGASi NG platform. The platform incorporates the latest Degasser Vacuum Controller (DVC) technology and fifth-generation StabiliX™ pumps, which the company says provide benchmark vacuum stability and quieter operation, with what it describes as unmatched reliability.
Error detection output
All DEGASi NG models now include an automated error control output. This signals the host system software in the unlikely event that the degasser is not functioning correctly, a feature intended to help ensure analytical results can be depended upon.
Six optimised models
According to Biotech Fluidics, each model in the DEGASi NG family fills a dedicated function and is tailored to fit most flow rates and solvent types, delivering degassing efficiency for the removal of dissolved gases. The DEGASi FlatFilm NG degasser incorporates flat film membrane technology, which enables a metal-free, chemically inert, biocompatible flow path. This complements the company’s established Teflon-AF single lumen concept.
PFAS-free option
The company points to increasing regulatory scrutiny and procurement restrictions on PFAS materials. The DEGASi LifeSci NG, which is based on a silicone membrane, is described as a new degasser that is completely free of all wetted fluorinated materials.
Reduced environmental impact
Each model in the DEGASi NG range uses a smaller PCB, fewer components and less housing material, which the company says reduces environmental impact.
Biotech Fluidics supplies fluidic system solutions, liquid transfer components and degassing systems to instrument developers, manufacturers and distributors from sites in Sweden, the USA and Japan.
For more information, visit: https://shorturl.at/GKQv6
Digital issue: Please click here for more information



